Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRSN Neurosense Therapeutics Ltd

盘前交易 03-04 05:05:19 EST

0.8500

+0.0000

0.00%

最高0.8650	最低0.8127	成交量7.96万
今开0.8300	昨收0.8500	日振幅6.15%
总市值2,839万	流通市值1,879万	总股本3,340万
成交额6.61万	换手率0.36%	流通股本2,211万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRSN","market":"US","secType":"STK","nameCN":"Neurosense Therapeutics Ltd","latestPrice":0.85,"timestamp":1772571600000,"preClose":0.85,"halted":0,"volume":79620,"delay":0,"changeRate":0,"floatShares":22107900,"shares":33396600,"eps":-0.377806,"marketStatus":"盘前交易","change":0,"latestTime":"03-04 05:05:19 EST","open":0.83,"high":0.865,"low":0.8127,"amount":66106.81398,"amplitude":0.061529,"askPrice":0.87,"askSize":45,"bidPrice":0.7134,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.377806,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772634600000},"marketStatusCode":1,"adr":0,"listingDate":1639026000000,"exchange":"NASDAQ","adjPreClose":0.85,"postHourTrading":{"tag":"盘后","latestPrice":0.8521,"preClose":0.85,"latestTime":"19:57 EST","volume":1196,"amount":1024.964,"timestamp":1772585848772,"change":0.0021,"changeRate":0.002471,"amplitude":0.022941},"volumeRatio":0.815473485045541},"requestUrl":"/m/hq/s/NRSN","defaultTab":"news","newsList":[{"id":"2595773919","title":"Neurosense Therapeutics Ltd.盘中异动 早盘快速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595773919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595773919?lang=zh_cn&edition=full","pubTime":"2025-12-30 23:28","pubTimestamp":1767108514,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日23时28分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅下跌5.26%。截至发稿，该股报0.720美元/股，成交量5.755万股，换手率0.19%，振幅3.55%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.79%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232835a6e1e64b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232835a6e1e64b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","NRSN","LENZ","BK4007"],"gpt_icon":0},{"id":"1199570378","title":"Neurosense Therapeutics Ltd - 在加拿大恢复Primec在肌萎缩侧索硬化症中的监管进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1199570378","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199570378?lang=zh_cn&edition=full","pubTime":"2025-12-04 21:41","pubTimestamp":1764855672,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd - 在加拿大恢复Primec在肌萎缩侧索硬化症中的监管进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"1171567202","title":"Neurosense Therapeutics Ltd获Noble Capital首次覆盖，评级\"跑赢大盘\"，目标价9美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171567202","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171567202?lang=zh_cn&edition=full","pubTime":"2025-10-14 21:30","pubTimestamp":1760448619,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd近日获得Noble Capital的首次研究覆盖。该投资银行给予这家公司\"跑赢大盘\"的投资评级，并设定目标股价为9美元。\n这一评级反映了Noble Capital对Neurosense Therapeutics Ltd未来发展前景的乐观预期。目标价9美元的设定为投资者提供了明确的价格参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"1189713433","title":"Neurosense Therapeutics Ltd的Primec产品在降低阿尔茨海默病生物标志物方面取得统计学显著效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1189713433","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189713433?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:10","pubTimestamp":1759756218,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd宣布，其Primec产品在降低阿尔茨海默病生物标志物方面实现了统计学上的显著效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2569791942","title":"Neurosense Therapeutics Ltd.盘中异动 临近收盘急速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569791942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569791942?lang=zh_cn&edition=full","pubTime":"2025-09-23 03:53","pubTimestamp":1758570782,"startTime":"0","endTime":"0","summary":"北京时间2025年09月23日03时53分，Neurosense Therapeutics Ltd.股票出现异动，股价快速上涨5.11%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.95%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923035302a43d0065&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923035302a43d0065&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","NRSN","BK4007"],"gpt_icon":0},{"id":"1191175580","title":"Neurosense Therapeutics Ltd初步2期道路试验结果显示脑细胞连接健康状况改善，安全性良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1191175580","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191175580?lang=zh_cn&edition=full","pubTime":"2025-09-11 02:31","pubTimestamp":1757529074,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd初步2期道路试验结果显示脑细胞连接健康状况改善，安全性良好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"1192691620","title":"Neurosense Therapeutics：基线Nfl调整后的分析确认，在考虑患者变异性后观察到的效益仍保持一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1192691620","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192691620?lang=zh_cn&edition=full","pubTime":"2025-09-02 20:41","pubTimestamp":1756816890,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics：基线Nfl调整后的分析确认，在考虑患者变异性后观察到的效益仍保持一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"1106841541","title":"Neurosense Therapeutics Ltd：通过NFL调整的MMRM分析证实18个月时具有统计显著性效果(P=0.03)","url":"https://stock-news.laohu8.com/highlight/detail?id=1106841541","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106841541?lang=zh_cn&edition=full","pubTime":"2025-09-02 20:39","pubTimestamp":1756816754,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd：通过NFL调整的MMRM分析证实18个月时具有统计显著性效果(P=0.03)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"gpt_icon":0},{"id":"1193122966","title":"Neurosense Therapeutics Ltd：公布其ALS药物Primec的2B期Paradigm研究18个月数据新分析结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1193122966","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193122966?lang=zh_cn&edition=full","pubTime":"2025-09-02 20:38","pubTimestamp":1756816706,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd：公布其ALS药物Primec的2B期Paradigm研究18个月数据新分析结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"gpt_icon":0},{"id":"2517948396","title":"Neurosense Therapeutics Ltd.盘中异动 急速拉升8.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948396?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185111,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅上涨8.18%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.08%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223151abe9b0bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223151abe9b0bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2516665912","title":"Neurosense Therapeutics Ltd.盘中异动 临近收盘快速下跌5.19%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516665912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516665912?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:00","pubTimestamp":1741035611,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日05时00分，Neurosense Therapeutics Ltd.股票出现波动，股价快速下跌5.19%。截至发稿，该股报1.05美元/股，成交量19.369万股，换手率0.83%，振幅9.03%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.20%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304050011abe69e8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304050011abe69e8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRSN"],"gpt_icon":0},{"id":"2514432004","title":"Neurosense Therapeutics Ltd.盘中异动 快速上涨5.61%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514432004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514432004?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:30","pubTimestamp":1740753024,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时30分，Neurosense Therapeutics Ltd.股票出现波动，股价快速上涨5.61%。截至发稿，该股报1.13美元/股，成交量1.564万股，换手率0.07%，振幅1.87%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.00%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223024a2580080&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223024a2580080&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2514801267","title":"Neurosense Therapeutics Ltd.盘中异动 快速跳水5.60%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514801267?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:24","pubTimestamp":1740504293,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日01时24分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅下挫5.60%。截至发稿，该股报1.02美元/股，成交量4.1206万股，换手率0.18%，振幅6.45%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.28%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226012453a253ad9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226012453a253ad9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2512169247","title":"Neurosense Therapeutics Ltd.盘中异动 快速拉升5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512169247?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:09","pubTimestamp":1739891370,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时09分，Neurosense Therapeutics Ltd.股票出现波动，股价快速拉升5.63%。截至发稿，该股报1.22美元/股，成交量3.3588万股，换手率0.14%，振幅4.05%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.69%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021823093096279ede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021823093096279ede&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2508514259","title":"Neurosense Therapeutics Ltd.盘中异动 股价大涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508514259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508514259?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:48","pubTimestamp":1738594089,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时48分，Neurosense Therapeutics Ltd.股票出现波动，股价急速拉升6.00%。截至发稿，该股报1.18美元/股，成交量4.2066万股，换手率0.18%，振幅3.60%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.30%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224809987971f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224809987971f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","BK4139","LENZ"],"gpt_icon":0},{"id":"2508994861","title":"Neurosense Therapeutics Ltd.盘中异动 下午盘快速上涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508994861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508994861?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:00","pubTimestamp":1738353636,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时00分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅上涨5.63%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.69%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020104003696151099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020104003696151099&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRSN"],"gpt_icon":0},{"id":"2506058583","title":"Neurosense Therapeutics Ltd.盘中异动 下午盘股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506058583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506058583?lang=zh_cn&edition=full","pubTime":"2025-01-28 02:25","pubTimestamp":1738002359,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日02时25分，Neurosense Therapeutics Ltd.股票出现波动，股价急速下挫5.45%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.72%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280225599874d2ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280225599874d2ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2505861513","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌6.19%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505861513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505861513?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:03","pubTimestamp":1737731017,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时03分，Neurosense Therapeutics Ltd.股票出现波动，股价快速跳水6.19%。截至发稿，该股报1.06美元/股，成交量3.3792万股，换手率0.15%，振幅3.45%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.55%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124230337a22e6177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124230337a22e6177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2505706824","title":"Neurosense Therapeutics Ltd.盘中异动 临近收盘急速下挫5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505706824","media":"市场透视","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505706824?lang=zh_cn&edition=full","pubTime":"2025-01-23 04:48","pubTimestamp":1737578921,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日04时48分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅下挫5.31%。截至发稿，该股报1.07美元/股，成交量12.353万股，换手率0.53%，振幅5.31%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.48%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123044841abb4f154&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123044841abb4f154&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2504816019","title":"Neurosense Therapeutics Ltd.盘中异动 早盘大幅下跌5.36%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504816019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504816019?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:26","pubTimestamp":1737127593,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时26分，Neurosense Therapeutics Ltd.股票出现波动，股价快速下跌5.36%。截至发稿，该股报1.06美元/股，成交量2.521万股，换手率0.11%，振幅3.57%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为1.00%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117232633abaebd57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117232633abaebd57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRSN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurosense-tx.com","stockEarnings":[{"period":"1week","weight":0.0379},{"period":"1month","weight":-0.0761},{"period":"3month","weight":-0.3089},{"period":"6month","weight":-0.2273},{"period":"1year","weight":-0.1905},{"period":"ytd","weight":0.1053}],"compareEarnings":[{"period":"1week","weight":-0.0102},{"period":"1month","weight":-0.0168},{"period":"3month","weight":-0.0052},{"period":"6month","weight":0.0481},{"period":"1year","weight":0.1654},{"period":"ytd","weight":-0.0023}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuroSense Therapeutics Ltd.于2017年2月13日在以色列注册成立。该公司是一家临床阶段的生物技术公司，专注于发现和开发针对神经退行性疾病患者的治疗方法，包括肌萎缩性侧索硬化症（ALS）、阿尔茨海默病（AD）和帕金森病（PD）。公司的主要候选治疗药物PrimeC是一种新型的缓释口服制剂，由两种FDA批准的药物环丙沙星和塞来昔布组成的固定剂量组合。PrimeC旨在通过调节microRNA合成、铁积累和神经炎症来治疗ALS，所有这些都是ALS病理的标志。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.157004},{"month":2,"riseRate":0.6,"avgChangeRate":0.184296},{"month":3,"riseRate":0.4,"avgChangeRate":0.050948},{"month":4,"riseRate":0.5,"avgChangeRate":-0.151693},{"month":5,"riseRate":0.25,"avgChangeRate":-0.004252},{"month":6,"riseRate":0.75,"avgChangeRate":0.40415},{"month":7,"riseRate":0,"avgChangeRate":-0.235872},{"month":8,"riseRate":0.5,"avgChangeRate":-0.118473},{"month":9,"riseRate":0.5,"avgChangeRate":0.06987},{"month":10,"riseRate":0,"avgChangeRate":-0.14429},{"month":11,"riseRate":0.75,"avgChangeRate":0.430569},{"month":12,"riseRate":0.25,"avgChangeRate":-0.202897}],"exchange":"NASDAQ","name":"Neurosense Therapeutics Ltd","nameEN":"Neurosense Therapeutics Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neurosense Therapeutics Ltd(NRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neurosense Therapeutics Ltd,NRSN,Neurosense Therapeutics Ltd股票,Neurosense Therapeutics Ltd股票老虎,Neurosense Therapeutics Ltd股票老虎国际,Neurosense Therapeutics Ltd行情,Neurosense Therapeutics Ltd股票行情,Neurosense Therapeutics Ltd股价,Neurosense Therapeutics Ltd股市,Neurosense Therapeutics Ltd股票价格,Neurosense Therapeutics Ltd股票交易,Neurosense Therapeutics Ltd股票购买,Neurosense Therapeutics Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neurosense Therapeutics Ltd(NRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}